Table 1.
Characteristic | No. of Patients (%) | P | |
---|---|---|---|
MBC (1,111) | FBC (2,151) | ||
Year of diagnosis | |||
1998–2000 | 186 (16.7) | 345 (16.0) | 0.753 |
2001–2003 | 332 (29.9) | 629 (29.2) | |
2004–2007 | 593 (53.4) | 1,177 (54.7) | |
Age, years | |||
<40 | 25 (2.3) | 40 (1.9) | 0.985 |
40–49 | 116 (10.4) | 225 (10.5) | |
50–59 | 260 (23.4) | 512 (23.8) | |
60–69 | 302 (27.2) | 590 (27.4) | |
70–79 | 244 (22.0) | 466 (21.7) | |
>80 | 164 (14.8) | 318 (14.8) | |
Race/ethnic | |||
White | 953 (85.8) | 1,867 (86.8) | 0.419 |
Black | 103 (9.3) | 171 (7.9) | |
Othera | 55 (5.0) | 113 (5.3) | |
Marital status | |||
Single | 292 (26.3) | 554 (25.8) | 0.745 |
Married | 819 (73.7) | 1,597 (74.2) | |
AJCC T stage | |||
T1mic | 35 (3.2) | 58 (2.7) | 0.965 |
T1a | 34 (3.1) | 66 (3.1) | |
T1b | 104 (9.4) | 206 (9.6) | |
T1c | 467 (42.0) | 903 (42.0) | |
T2 | 471 (42.4) | 918 (42.7) | |
AJCC N stage | |||
N0 | 661 (59.5) | 1,295 (60.2) | 0.881 |
N1 | 366 (32.9) | 690 (32.1) | |
N2 | 84 (7.6) | 166 (7.7) | |
Histological | |||
Ductal | 943 (84.9) | 1,536 (71.4) | <0.001 |
Lobular | 7 (0.6) | 213 (9.9) | |
Other | 161 (14.5) | 402 (18.7) | |
Grade | |||
I | 171 (15.4) | 316 (14.7) | 0.833 |
II | 569 (51.2) | 1,121 (52.1) | |
III | 371 (33.4) | 714 (33.2) | |
ER | |||
Negative | 49 (4.4) | 110 (5.1) | 0.377 |
Positive | 1,062 (95.6) | 2,041 (94.9) | |
PR | |||
Negative | 171 (15.4) | 330 (15.3) | 0.970 |
Positive | 940 (84.6) | 1821 (84.7) | |
Chemotherapy | |||
No | 684 (61.6) | 1,318 (61.3) | 0.871 |
Yes | 427 (38.4) | 883 (38.7) | |
Radiotherapy | |||
No | 846 (76.1) | 1,642 (76.3) | 0.904 |
Yes | 265 (23.9) | 509 (23.7) | |
Surgery | |||
No | 8 (0.7) | 8 (0.4) | 0.370 |
BCS | 129 (11.6) | 261 (12.1) | |
Mastectomy | 974 (87.7) | 1,882 (87.5) |
aAmerican Indian/AK Native, Asian/Pacific Islander.
Abbreviations: MBC, male breast cancer; FBC, female breast cancer; AJCC, American Joint Committee on Cancer system; ER, estrogen-receptor; PR, progesterone receptor; BCS, breast conserving surgery.